The drive to accelerate drug development has highlighted the benefit in using RTSM systems within early phase cohort trials.
Barry O’Gorman
Advertisement
Articles by Barry O’Gorman
Advertisement
Latest Updated Articles
Applying New Technology to Randomization, Cohort Management and Dosing in Multi-center Early Phase TrialsPublished: January 15th 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
Honing the Power of AI for Next Generation Trial Oversight and Execution
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
